Eam Global Investors LLC Ocular Therapeutix, Inc Transaction History

Eam Global Investors LLC

  • $401 Million
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 11, 2021
SELL
$15.82 - $22.11 $2.59 Million - $3.62 Million
-163,584 Closed
0 $0
Q4 2020

Feb 11, 2021
SELL
$7.91 - $22.95 $327,339 - $949,739
-41,383 Reduced 20.19%
163,584 $3.39 Million
Q3 2020

Nov 13, 2020
SELL
$7.36 - $9.87 $444,168 - $595,644
-60,349 Reduced 22.75%
204,967 $1.56 Million
Q1 2020

May 13, 2020
BUY
$3.95 - $7.4 $1.05 Million - $1.96 Million
265,316 New
265,316 $1.31 Million

Others Institutions Holding OCUL

# of Institutions
148
Shares Held
123M
Call Options Held
185K
Put Options Held
507K
View Full List

About OCULAR THERAPEUTIX, INC

OCUL Quotes by TradingView
  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $526M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Eam Global Investors LLC Portfolio

Follow Eam Global Investors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eam Global Investors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eam Global Investors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email